Shota Fukuoka
Overview
Explore the profile of Shota Fukuoka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
2029
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Udagawa S, Osumi H, Ooki A, Shimozaki K, Wakatsuki T, Fukuoka S, et al.
Int J Clin Oncol
. 2025 Feb;
PMID: 40014187
Background: Early tumor shrinkage (ETS) and depth of response (DpR) are early indicators of survival in patients with metastatic colorectal cancer (mCRC) undergoing anti-epidermal growth factor receptor monoclonal antibody treatment....
2.
Shimozaki K, Ooki A, Yoshino K, Tamba M, Udagawa S, Osumi H, et al.
Ther Adv Med Oncol
. 2025 Feb;
17:17588359251322670.
PMID: 40012706
Background: Although the emergence of immunotherapy has benefited patients with advanced gastric cancer (AGC), the magnitude of the benefit among real-world patients with HER2-negative AGC remains unclear. Objectives: The current...
3.
Tamba M, Okamura A, Osumi H, Imamura Y, Kanamori J, Ogura M, et al.
Esophagus
. 2025 Jan;
PMID: 39755858
Background And Purpose: It remains unclear whether the lymph-node ratio (LNR) is a relevant factor for the risk of recurrence following neoadjuvant chemotherapy (nCT) with docetaxel, cisplatin, and 5-fluorouracil (DCF),...
4.
Terayama M, Okamura A, Oki A, Kuriyama K, Takahashi N, Tamura M, et al.
Dis Esophagus
. 2024 Dec;
38(1.
PMID: 39696976
Recently, neoadjuvant chemotherapy comprising docetaxel, cisplatin, and 5-fluorouracil showed promising efficacy for esophageal squamous cell carcinoma. However, some patients do not achieve curative resection despite neoadjuvant chemotherapy using these drugs....
5.
Hatori M, Fukuoka S, Kimura S, Kawakami K, Yamaguchi K, Yamaguchi M
Oncology
. 2024 Dec;
1-9.
PMID: 39647476
Introduction: Cisplatin-based highly emetogenic chemotherapy is recommended in combination with neurokinin-1 receptor antagonist, 5-hydroxytryptamine-3-receptor antagonist (5HT3RA), dexamethasone (DEX), and olanzapine. However, olanzapine is contraindicated in patients with preexisting diabetes mellitus...
6.
Tsuge A, Watanabe S, Kawazoe A, Togashi Y, Itahashi K, Masuda M, et al.
Cancer Immunol Res
. 2024 Nov;
13(2):273-285.
PMID: 39602577
Regulatory T (Treg) cells play key roles in cancer immunity by suppressing a range of antitumor immune responses and contributing to resistance to PD-1 blockade therapy. Given their critical roles...
7.
Ri M, Nishie N, Ohashi M, Fukuoka S, Yamaguchi K, Makuuchi R, et al.
Gastric Cancer
. 2024 Nov;
28(1):122-130.
PMID: 39509007
Background: It is essential to ensure optimal adherence to adjuvant chemotherapy regimens following gastric cancer surgery. However, treatment intensity for S-1 as adjuvant chemotherapy has not as yet been compared...
8.
Cousin S, Guegan J, Shitara K, Palmieri L, Metges J, Pernot S, et al.
Mol Cancer
. 2024 Sep;
23(1):197.
PMID: 39272096
Anti-angiogenic agents elicit considerable immune modulatory effects within the tumor microenvironment, underscoring the rationale for synergistic clinical development of VEGF and immune checkpoint inhibitors in advanced gastric cancer (AGC). Early...
9.
Fukuda K, Osumi H, Yoshinami Y, Ooki A, Takashima A, Wakatsuki T, et al.
J Cancer Res Clin Oncol
. 2024 Jul;
150(7):369.
PMID: 39066951
Purpose: To investigate circulating tumor DNA (ctDNA) RAS mutant (MT) incidence before salvage-line treatment and the clinicopathological features and molecular biological factors associated with the efficacy of anti-epithelial growth factor...
10.
Tsuji G, Shimomura A, Fukuoka S, Oki M
Genes Genet Syst
. 2024 Feb;
99.
PMID: 38382922
The freezing-thawing (F/T) method for fusing giant unilamellar vesicles (GUVs) can provide substrates, enzymes and membrane material simultaneously and repetitively, and is useful for constructing a recursive model of an...